Table 3 Adverse events in study groups
SZC group (n = 60) | SPS group (n = 60) | Comparison bet. groups p | |
|---|---|---|---|
Serious AE | 2 (3.3%) | 3 (5%) | 1.000 |
AE causing drug discontinuation | 0 | 1 (1.6%) | 1.000 |
GIT AEs | |||
- Diarrhea | 1 (1.6%) | 2 (3.3%) | 1.000 |
- Constipation | 2 (3.3%) | 3 (5%) | 1.000 |
- Nausea | 0 (0.0) | 2 (3.3%) | 0.495 |
Headache | 1 (1.6%) | 1 (1.6%) | 1.000 |
Hypokalemia | 0 | 0 | - |
Poor palatability | 17 (28.3%) | 2 (3.3%) | < 0.001* |